| 168331 | 168331 | Uterine Artery Embolization for Symptomatic Fibroids | Completed | No Results Available | Uterine Fibroids|Menorrhagia|Adenomyosis | Procedure: Uterine Artery Embolization | https://ClinicalTrials.gov/show/NCT00354471 |
| 168332 | 168332 | PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function | Completed | No Results Available | Heart Failure, Congestive | Drug: rolofylline|Drug: Comparator: Placebo (unspecified) | https://ClinicalTrials.gov/show/NCT00354458 |
| 168333 | 168333 | A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD | Recruiting | No Results Available | Age-Related Macular Degeneration (AMD) | Drug: pegaptanib sodium (Macugen) | https://ClinicalTrials.gov/show/NCT00354445 |
| 168334 | 168334 | Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer | Completed | No Results Available | Hot Flashes|Prostate Cancer | Dietary Supplement: soy isoflavones|Dietary Supplement: soy protein isolate|Drug: venlafaxine|Drug: placebo | https://ClinicalTrials.gov/show/NCT00354432 |
| 168335 | 168335 | Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant | Terminated | No Results Available | Aplastic Anemia | Radiation: total-body irradiation|Drug: cyclophosphamide|Biological: anti-thymocyte globulin|Drug: cyclosporine|Procedure: umbilical cord blood transplantation|Drug: mycophenolate mofetil|Procedure: bone marrow aspiration|Genetic: DNA analysis|Biological: filgrastim | https://ClinicalTrials.gov/show/NCT00354419 |
| 168336 | 168336 | Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty | Completed | No Results Available | Myocardial Infarction | Drug: abciximab | https://ClinicalTrials.gov/show/NCT00354406 |
| 168337 | 168337 | Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma | Active, not recruiting | No Results Available | Malignant Mesothelioma | Drug: cisplatin|Drug: methotrexate|Drug: vinorelbine ditartrate|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy | https://ClinicalTrials.gov/show/NCT00354393 |
| 168338 | 168338 | Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study | Completed | No Results Available | Malaria | Drug: Methylene blue|Drug: Artesunate|Drug: Amodiaquine | https://ClinicalTrials.gov/show/NCT00354380 |
| 168339 | 168339 | Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas | Withdrawn | No Results Available | Crohn Disease | Drug: Certolizumab pegol | https://ClinicalTrials.gov/show/NCT00354367 |
| 168340 | 168340 | Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients | Completed | No Results Available | Chronic Obstructive Pulmonary Disease | Drug: Combivent | https://ClinicalTrials.gov/show/NCT00354354 |
| 168341 | 168341 | (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy | Completed | No Results Available | Anemia | Drug: epoetin beta [NeoRecormon] | https://ClinicalTrials.gov/show/NCT00354341 |
| 168342 | 168342 | Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy | Completed | No Results Available | Angina, Unstable|Myocardial Infarction|Ischemic Heart Disease | | https://ClinicalTrials.gov/show/NCT00354328 |
| 168343 | 168343 | DÉCISION+, a Continuous Professional Development Program to Improve Optimal Drug Prescription : a Feasibility Study | Completed | No Results Available | Choice Behavior | Behavioral: Continuous medical education (CME) | https://ClinicalTrials.gov/show/NCT00354315 |
| 168344 | 168344 | Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27 | Completed | No Results Available | Breast Cancer|Osteoporosis | Dietary Supplement: calcium carbonate|Dietary Supplement: calcium citrate|Dietary Supplement: cholecalciferol|Drug: alendronate sodium|Drug: calcium gluconate|Drug: risedronate sodium|Other: laboratory biomarker analysis|Procedure: dual x-ray absorptometry | https://ClinicalTrials.gov/show/NCT00354302 |
| 168345 | 168345 | VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia | Active, not recruiting | No Results Available | Leukemia | Drug: cytarabine|Drug: laromustine | https://ClinicalTrials.gov/show/NCT00354276 |
| 168346 | 168346 | Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen | Completed | No Results Available | Healthy | Biological: IMP321|Biological: saline | https://ClinicalTrials.gov/show/NCT00354263 |
| 168347 | 168347 | Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer | Completed | No Results Available | Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer | Drug: ispinesib | https://ClinicalTrials.gov/show/NCT00354250 |
| 168348 | 168348 | DARE: Diabetes in cArdiac REhabilitation | Completed | No Results Available | Type 2 Diabetes Mellitus|Coronary Artery Disease | Other: Conventional antidiabetic treatment|Other: Intensive insulin treatment | https://ClinicalTrials.gov/show/NCT00354237 |
| 168349 | 168349 | Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer | Completed | No Results Available | Gastric Cancer | Drug: capecitabine|Drug: oxaliplatin | https://ClinicalTrials.gov/show/NCT00354224 |
| 168350 | 168350 | Using Minimally Invasive Cardiac Output Data vs. Standard Care for Patients Emergently Admitted to the Intensive Care Unit Who Are Hemodynamically Unstable | Completed | No Results Available | Cardiac Output, High|Cardiac Output, Low | Device: minimally invasive cardiac output system consisting of arterial line sensor and cardiac output bedside monitor (device) | https://ClinicalTrials.gov/show/NCT00354211 |
| 168351 | 168351 | Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis | Terminated | No Results Available | Glomerulonephritis | Drug: pentoxifylline|Drug: corticosteroids | https://ClinicalTrials.gov/show/NCT00354198 |
| 168352 | 168352 | PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma | Terminated | No Results Available | Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Post-tr | Drug: tanespimycin|Drug: belinostat|Other: laboratory biomarker analysis|Other: pharmacological study | https://ClinicalTrials.gov/show/NCT00354185 |
| 168353 | 168353 | Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. | Terminated | Has Results | Leukemia|Myelodysplastic Syndromes | Biological: aldesleukin|Biological: filgrastim|Biological: natural killer cell (NK) therapy|Drug: cyclophosphamide|Drug: cyclosporine|Drug: fludarabine phosphate|Drug: methylprednisolone|Drug: mycophenolate mofetil|Procedure: Umbilical Cord Blood Transplantation (UCBT)|Radiation: Total body irradiation (TBI) | https://ClinicalTrials.gov/show/NCT00354172 |
| 168354 | 168354 | Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf) | Completed | Has Results | Heart Failure | Device: Implantable Hemodynamic Monitor (Chronicle® IHM), and IHM in combination with single chamber ICD (Chronicle ICD) | https://ClinicalTrials.gov/show/NCT00354159 |
| 168355 | 168355 | A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. | Completed | No Results Available | Leukemia, Nonlymphocytic, Acute | Drug: tipifarnib (R115777) | https://ClinicalTrials.gov/show/NCT00354146 |
| 168356 | 168356 | Controlled Trial of Deep Brain Stimulation in Early Patients With Parkinson's Disease | Active, not recruiting | No Results Available | Parkinson Disease | Device: Kinetra and Soletra (neurostimulator, Medtronic) | https://ClinicalTrials.gov/show/NCT00354133 |
| 168357 | 168357 | Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant | Completed | No Results Available | Acute Myeloblastic Leukemia|Lymphoblastic Leukemia|Myelodysplasia|Chronic Myeloid Leukemia|Myelofibrosis|Lympho-proliferative Diseases | Drug: Alentuzumab|Drug: Globulina antilinfocitaria | https://ClinicalTrials.gov/show/NCT00354120 |
| 168358 | 168358 | Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma | Terminated | Has Results | Anaplastic Large Cell Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma | Biological: monoclonal antibody SGN-30|Drug: therapeutic hydrocortisone|Drug: ifosfamide|Drug: carboplatin|Drug: etoposide|Drug: methotrexate|Drug: cytarabine|Other: pharmacological study|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT00354107 |
| 168359 | 168359 | [S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain. | Terminated | No Results Available | Pain | Drug: [S,S]-Reboxetine | https://ClinicalTrials.gov/show/NCT00354094 |
| 168360 | 168360 | WENBIT - Western Norway B Vitamin Intervention Trial | Completed | No Results Available | Coronary Artery Disease|Myocardial Infarction|Cerebrovascular Stroke | Drug: folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine)|Drug: folic acid, vitamin B12 (cyanocobalamin)|Drug: vitamin B6 (pyridoxine)|Drug: placebo | https://ClinicalTrials.gov/show/NCT00354081 |